Jimeng K. Hu
12 Middle Urumqi Road
Shanghai, 200040, China
Shanghai, 200040, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
pH-responsive chitosan-based nanoparticles for targeted delivery of nicotinamide mononucleotide in acute kidney injury therapy.
Journal: Colloids and surfaces. B, Biointerfaces
Published: May 23, 2026
Association between metabolic dysfunction-associated steatotic liver disease and risk for cardiovascular events in adults in Shanghai
Journal: Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi
Published: December 24, 2025
NOX4 suppresses malignant progression in prostate adenocarcinoma and functions as a potential diagnostic biomarker.
Journal: Translational andrology and urology
Published: December 09, 2025
Quantitative analysis and risk factors of high-grade encrustation in double-J stents after ureteroscopy and laser lithotripsy.
Journal: Urolithiasis
Published: October 14, 2025
Ginsenoside Rh2 targets SIRT1-mediated deacetylation to modulate ERα/AR balance and overcome endocrine therapy resistance in prostate cancer using 3D organoid models.
Journal: Cell biology and toxicology
Published: April 11, 2025
Correction to: Combining MTI‑31 with RAD001 inhibits tumor growth and invasion of kidney cancer by activating autophagy.
Journal: Journal of applied genetics
Published: November 15, 2023
Combining MTI-31 with RAD001 inhibits tumor growth and invasion of kidney cancer by activating autophagy.
Journal: Journal of applied genetics
Published: September 04, 2023
Protective Autophagy Attenuates the Cytotoxicity of MTI-31 in Renal Cancer Cells by Activating the ERK Pathway.
Journal: Applied biochemistry and biotechnology
Published: May 24, 2023
Repair of the Urethral Mucosa Defect Model Using Adipose-Derived Stem Cell Sheets and Monitoring the Fate of Indocyanine Green-Labeled Sheets by Near Infrared-II.
Journal: ACS biomaterials science & engineering
Published: October 06, 2022
Overexpression of Ubiquitin-Conjugating Enzyme E2C Is Associated with Worsened Prognosis in Prostate Cancer.
Journal: International journal of molecular sciences
Published: September 28, 2022
Last Updated: 09/26/2026